FindTrial
Sign In

Comparison of Ropivacaine and Bupivacaine for pain relief after major abdominal surgeries

Comparison of continuous epidural infusion of 0.125 percent Ropivacaine with 1 micro gram per millilitre of Fentanyl versus 0.125 percent Bupivacaine with 1 micro gram per millilitre of Fentanyl for postoperative analgesia for major abdominal surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/01/007715
Enrollment
60
Registered
2017-01-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Major abdominal surgeries

Interventions

Intervention1: Ropivacaine: Comparison of continuous epidural infusion of 0.125 percent Ropivacaine with 1 micro gram per millilitre of Fentanyl versus 0.125 percent Bupivacaine with 1 micro gram per

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anaesthesiology class I and II patients for major abdominal surgeries Age 18 to 65 years

Exclusion criteria

Exclusion criteria: American Society of Anaesthesiology class III and IV Infection at Injection site Patient refusal Coagulopathy or bleeding disorder Severe Hypovolemia Increased intracranial pressure Sepsis Pre existing neurological deficit and demyelinating lesion Severe spinal deformities

Design outcomes

Primary

MeasureTime frame
Haemodynamic parameters (Blood pressure mmHg., Pulse), visual analogue scale(0 to 10), level of sensory block, level of motor block (based on Bromage scale) were monitored for 24 hours postoperativelyTimepoint: Above parameters monitored for 24 hours postoperatively.—

Secondary

MeasureTime frame
NoneTimepoint: None—

Countries

India

Contacts

Public ContactShruti S Patil

Professor, Department of Anesthesia, Sion

gurukudalkar@yahoo.co.in9869134209

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026